Chester, NJ and Montreal, QC – Molecular Biometrics, a privately held metabolomics company, says it has opened a research and development facility in Montreal.
“It was a propitious time to set-up a research facility in Montreal to further develop our fertility product portfolio and to initiate new research in additional therapeutic fields, including maternal-fetal medicine and neurodegenerative diseases,” says Dr James Posillico, the company’s CEO. “There is a highly experienced pool of scientific talent for us to draw upon in Montreal, and the region has a long history of supporting breakthrough biomedical research.”
He says the facility will focus on the development and enhancement of the company’s technology platform which is based on metabolomic, bioinformatics and biospectroscopy sciences. He adds the technology is able to identify specific biomarkers in a given biological sample and convert the information into a novel metabolomic profile that is indicative of health or disease.